4.7 Article

Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes

Goran Petrovski et al.

Summary: The 1-year observational study evaluated the effect of a hybrid closed-loop system on glycemic control in children and adolescents with type 1 diabetes previously treated with multiple daily injections. The study found that the HCL system significantly improved glycemic outcomes, including HbA1c and Time in Ranges, immediately during the first month and maintained this improvement over the following year.

ACTA DIABETOLOGICA (2021)

Article Endocrinology & Metabolism

Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

Olivia J. Collyns et al.

Summary: The study found that the MiniMed Advanced Hybrid Closed-Loop (AHCL) system significantly improved glucose control in participants with type 1 diabetes, especially during the night. All age groups showed improvements, with adolescents showing the most significant improvement.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes

Pilar Isabel Beato-Vibora et al.

Summary: The study aimed to evaluate the impact of AHCL system implementation on glycemic control in patients with type 1 diabetes. Results showed that after using the AHCL system, patients had significantly increased TIR, reduced time in hyperglycemia, and no significant change in hypoglycemia time.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes

Laurel H. Messer et al.

Summary: A study on youth using Control-IQ technology for 6 months showed significant improvement in glycemic control, especially for those with higher baseline HbA1c. System use was high at 6 months, with only a small proportion discontinuing use, indicating potential for sustaining results long term.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

First year on commercial hydrid closed-loop system-experience on 111 children and adolescents with type 1 diabetes

Tero Varimo et al.

Summary: The study investigated the impact of the hybrid closed-loop system (HCL) on glycemic control in children and adolescents with type 1 diabetes during the first year of use. Results showed significant improvements in all measures of glycemic control, except for HbA1c, and the positive effects were sustained throughout the year.

PEDIATRIC DIABETES (2021)

Letter Endocrinology & Metabolism

Therapeutic Contract in Adolescents Using Hybrid Closed Loop System

Gianluca Tornese et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity

Gianluca Tornese et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Meeting Abstract Endocrinology & Metabolism

Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D

Anders L. Carlson et al.

DIABETES (2020)

Article Endocrinology & Metabolism

Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study

Melissa H. Lee et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Rayhan A. Lal et al.

DIABETES CARE (2019)

Article Endocrinology & Metabolism

Efficacy and Safety of Real-Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old

Parisa Salehi et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study

Barbora Paldus et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Gregory P. Forlenza et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes in adolescence

Fergus J. Cameron et al.

PEDIATRIC DIABETES (2018)

Review Medicine, General & Internal

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

Eleni Bekiari et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

Eleni Bekiari et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Endocrinology & Metabolism

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

Michael P. Stone et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Review Endocrinology & Metabolism

Diabetes Distress Among Adolescents with Type 1 Diabetes: a Systematic Review

Virginia Hagger et al.

CURRENT DIABETES REPORTS (2016)

Article Endocrinology & Metabolism

Association of HbA1c to BOLUS Scores Among Youths with Type 1 Diabetes

Mark A. Clements et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2016)

Letter Medicine, General & Internal

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

Richard M. Bergenstal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Pharmacology & Pharmacy

Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.

S. Saturni et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Endocrinology & Metabolism

Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

E. Cacciari et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)